Belmont, CA, United States of America

BinQing Wei

USPTO Granted Patents = 29 

Average Co-Inventor Count = 6.7

ph-index = 6

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
29 patents (USPTO):

Title: **BinQing Wei: A Pioneer in HPK1 Research and Patent Innovations**

Introduction

BinQing Wei, based in Belmont, CA, has made significant contributions in the field of pharmaceutical innovations, particularly focusing on the development of compounds that target hematopoietic kinase 1 (HPK1). With an impressive portfolio of 29 patents, Wei exhibits a strong commitment to advancing medical treatments through his inventive solutions.

Latest Patents

Among Wei's latest patents are the groundbreaking "Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof." This invention includes variations of the spirocyclic compounds designed to serve as effective inhibitors of HPK1. These compounds are particularly useful for treating HPK1-dependent disorders and enhancing immune responses. Wei's patents also detail methods for inhibiting HPK1, treating related disorders, and preparing these innovative compounds for medical use. Additionally, Wei has focused on Azaindoles as inhibitors of HPK1, expanding the range of therapeutic options available for HPK1-related conditions.

Career Highlights

Throughout his career, BinQing Wei has collaborated with notable companies such as Genentech, Inc. This experience has provided him with a platform to develop his ideas into valuable medical innovations, significantly impacting the research and development landscape in pharmaceuticals.

Collaborations

Wei's work has been enriched by collaborations with esteemed colleagues, including Timothy Heffron and James John Crawford. This collective intellectual synergy has driven forward-thinking projects and has contributed to the successful development of innovative therapeutic compounds.

Conclusion

In summary, BinQing Wei is a leading figure in the field of HPK1 research, with a robust portfolio of patents that illustrate his dedication to finding novel therapies for complex medical disorders. His ongoing work continues to shape the future of healthcare through innovative approaches and collaborative efforts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…